摘要:
Novel compounds of Formula (1.0) are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of formula (1.0) to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.
摘要:
Novel compounds of Formula (1.0) are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of Formula (1.0) to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.
摘要:
Novel compounds of Formula (1.0) are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of the formula to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.
摘要:
Novel compounds of Formula (1.0) are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of formula (1.0) to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.
摘要:
Novel compounds of Formula (1.0) are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of Formula (1.0) to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.
摘要:
Nouveaux composés de di- et tri- O-acétyle-23-O-démycinosyle-4''-O-iso-valeryltylosine et leurs sels pharmaceutiquement acceptable, présentant une activité anti-bactérienne améliorée tout en assurant des niveaux sanguins plus élevés que d'autres composés dérivés de la tylosine. Ces composés présentent la formule structurale (I) où R est acétyle ou hydrogène et Z est par exemple O ou (II). Sont également décrits des procédés de désacylation sélective des positions 2' et 4'' de 3, 2', 4'', 4'''-tetra-O-acyltylosine ou de 2', 4'', 4'''-tri-O-acyltylosine et d'acylation sélective de 2', 4''-di-O-acyltylosine et de 2', 4'', 4'''-tri-O-acyltylosine.